论文部分内容阅读
目的:观察米索前列醇联合人工破膜在临床应用效果对比。方法:年龄21~34岁,孕周40±2周,头位单胎,无妊娠合并症及并发症孕妇150例,随机分成观察组75例,对照组75例,观察组在潜伏期用米索前列醇30μg阴道塞入配合活跃期(宫口开大3~4cm)时行人工破膜。结果:观察组第1产程、第2产程平均产程时间明显比对照组缩短(P<0.01),产后出血及新生儿窒息率显著低于对照组(P<0.05)。剖宫产率明显下降。结论:米索前列醇联合人工破膜在临床应用安全有效,值得推广应用。
Objective: To observe the effect of misoprostol combined with artificial rupture in clinical application. Methods: A total of 150 pregnant women, aged 21-34 years and gestational weeks 40 ± 2 weeks, with single head fetus, no pregnancy complications and complications, were randomly divided into observation group (75 cases) and control group (75 cases) Epithelial 30ug vaginal plug with the active phase (cervix 3 ~ 4cm) artificial rupture of the line. Results: The average duration of labor during the first stage of labor and the second stage of labor in the observation group was significantly shorter than that in the control group (P <0.01). The rate of postpartum hemorrhage and neonatal asphyxia was significantly lower than that in the control group (P <0.05). Cesarean section rate decreased significantly. Conclusion: Misoprostol combined with artificial rupture of the membrane in the clinical application of safe and effective, it is worth promoting application.